Edition:
United Kingdom

People: Novavax Inc (NVAX.OQ)

NVAX.OQ on NASDAQ Stock Exchange Global Select Market

0.53USD
22 Apr 2019
Change (% chg)

$0.01 (+1.28%)
Prev Close
$0.52
Open
$0.52
Day's High
$0.55
Day's Low
$0.51
Volume
2,705,225
Avg. Vol
2,903,921
52-wk High
$2.58
52-wk Low
$0.49

Trizzino, John 

Mr. John J. Trizzino is Senior Vice President, Chief Business Officer, Chief Financial Officer and Treasurer of Novavax, Inc. He previously served as the Company’s Senior Vice President, Business Development from August 2010 to September 2011, and its Senior Vice President, International and Government Alliances from July 2009 to July 2010. Prior to joining the Company, Mr. Trizzino was the CEO of Immunovaccine from September 2011 to September 2013, VP, Vaccine Franchise at Medimmune, LLC, Senior Vice President, Business Development at ID Biomedical, and Vice President, Business Development in the Medical Group of Henry Schein, Inc. following his position as Vice President, General Manager of its GIV division. Mr. Trizzino also serves on the board of directors of The Maryland Tech Council. Mr. Trizzino received a B.S. from Long Island University, CW Post and a M.B.A. from New York University.

Basic Compensation

Total Annual Compensation, USD 515,247
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 432,500
Fiscal Year Total, USD 947,747

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Young

533,780

Stanley Erck

2,771,680

John Trizzino

947,747

Gregory Glenn

1,221,250

John Herrmann

913,317

Jody Lichaa

--
As Of  31 Dec 2017